跳至主要内容
临床试验/NCT05449171
NCT05449171已完成不适用

Efficacy of the Association of Hyaluronic Acid With High Molecular Weight, α-lipoic Acid (ALA), Magnesium, Vitamin B6 and Vitamin D, in the Prevention of Spontaneous Abortion in Patients at Risk

Lo.Li.Pharma s.r.l2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Incidence of metrorrhagia and/or pelvic pain in the first trimester of gestation.

研究概览

简要总结

The study aims to verify if the association of high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D, reduces the risk of miscarriage in patients at risk.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • two or more previous spontaneous first trimester abortions without apparent risk factors (idiopathic polyabortion)
  • Endocrinopathies
  • Autoimmune diseases
  • Thrombophililic or coagulation diseases

排除标准

  • Multiple pregnancies
  • Presence of genetic abnormalities of one or both partners leading to increased risk of fetal aneuploidies
  • Presence of Mullerian abnormalities in the uterus
  • Symptoms present at recruitment such as pelvic pain or metrorrhagia

研究组 & 干预措施

Control group

No Intervention

Treatment group

Experimental

干预措施: high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D (Other)

结局指标

主要结局

Incidence of metrorrhagia and/or pelvic pain in the first trimester of gestation.

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

High Molecular Weight Hyaluronic Acid, α-lipoic... | 临床试验